https://www.selleckchem.com/products/gdc-0068.html
Bloodstream infections (BSI) are often caused by drug-resistant pathogens, and novel antimicrobials are needed. We examined the activity of imipenem/relebactam against BSI pathogens from US and Canada 99% of non-Morganellaceae Enterobacterales, including 100% of MDR isolates, and 94% of Pseudomonas aeruginosa were imipenem/relebactam-susceptible. Imipenem/relebactam could provide an important treatment option.Thermal treatment is routinely used to reactivate the spent granular activated carbon (GAC) from water purification faci
Like
Comment
Share
